| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 582.70M | 542.50M | 463.40M | 364.40M | 285.10M |
| Gross Profit | 135.20M | 193.80M | 114.70M | 67.40M | 29.90M |
| EBITDA | 114.60M | 127.00M | 108.90M | 70.30M | 43.20M |
| Net Income | 31.20M | 47.80M | 44.20M | 8.10M | -13.60M |
Balance Sheet | |||||
| Total Assets | 660.90M | 615.60M | 537.20M | 536.00M | 532.50M |
| Cash, Cash Equivalents and Short-Term Investments | 18.80M | 16.50M | 11.70M | 38.30M | 12.50M |
| Total Debt | 208.50M | 184.40M | 172.70M | 230.30M | 263.70M |
| Total Liabilities | 306.40M | 268.70M | 269.00M | 316.40M | 326.00M |
| Stockholders Equity | 354.50M | 346.90M | 268.20M | 219.60M | 206.50M |
Cash Flow | |||||
| Free Cash Flow | 92.20M | 70.50M | 73.70M | 91.60M | 57.70M |
| Operating Cash Flow | 103.90M | 88.90M | 91.90M | 98.50M | 65.20M |
| Investing Cash Flow | -45.10M | -40.50M | -18.20M | -6.90M | -7.00M |
| Financing Cash Flow | -57.50M | -42.90M | -102.10M | -65.80M | -47.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £241.49M | 7.56 | 9.00% | 7.08% | 7.41% | -34.62% | |
65 Neutral | £1.55B | 6.72 | 105.88% | 3.99% | 4.39% | -1.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | £634.40M | 8.84 | -113.93% | 1.40% | 3.94% | ― | |
53 Neutral | £33.75M | -1.20 | 63.25% | ― | -2.65% | -18.90% | |
52 Neutral | £70.03M | -3.03 | -43.73% | ― | -38.65% | -792.57% | |
47 Neutral | £620.31M | -7.96 | -90.46% | 4.48% | -30.52% | -2064.92% |